Tumor irradiation acts somewhat as an in situ vaccine as it endorses the release of tumor-associated antigens that prompt antigen-presenting cells to migrate to draining lymph nodes, where they prime cytotoxic CD8+ T cells to generate an adaptive immune response including increased expression of T cell receptors [189]. This evidence concerns the gene CD8A and neoplasm.